A comprehensive sexual wellness blend combining five complementary compounds for enhanced desire, arousal, and bonding.
This advanced sexual wellness capsule combines five compounds with complementary mechanisms addressing the central nervous system, hormonal, vascular, and psychological dimensions of sexual function. PT-141 (Bremelanotide) is a melanocortin receptor agonist that was FDA-approved in 2019 as Vyleesi for hypoactive sexual desire disorder in premenopausal women, making it the only centrally-acting approved sexual desire medication. Oxytocin is the endogenous neuropeptide associated with bonding, trust, and arousal, with demonstrated effects on sexual motivation and partner bonding. N-Acetyl L-Tyrosine (NALT) provides a bioavailable precursor to dopamine and norepinephrine, supporting the catecholaminergic signaling that underlies sexual motivation and reward. Kisspeptin is a hypothalamic neuropeptide that stimulates GnRH (gonadotropin-releasing hormone) release, which drives downstream LH and FSH production and ultimately sex hormone synthesis. VIP (Vasoactive Intestinal Peptide) is a neuropeptide with vasodilatory and neuromodulatory properties that supports genital blood flow and arousal responses. Together, these five compounds provide a comprehensive approach to sexual wellness through central desire (PT-141), bonding (Oxytocin), dopaminergic motivation (NALT), hormonal optimization (Kisspeptin), and vascular support (VIP).
* Benefits based on preclinical/animal research unless otherwise noted.
PT-141 activates melanocortin receptors MC3R and MC4R in the hypothalamus and limbic system, triggering central nervous system pathways that increase sexual desire and motivation independent of vascular mechanisms. Oxytocin acts on oxytocin receptors in the limbic system, nucleus accumbens, and spinal cord to enhance bonding, arousal, and the subjective experience of intimacy. NALT is converted to L-Tyrosine and then to L-DOPA and dopamine through the catecholamine synthesis pathway, supporting dopaminergic reward signaling in the mesolimbic system that drives sexual motivation. Kisspeptin activates KISS1R receptors on GnRH neurons in the hypothalamus, stimulating pulsatile GnRH release that drives LH and FSH secretion from the pituitary, ultimately increasing testosterone and estrogen production. VIP activates VIP receptors (VPAC1/VPAC2) on smooth muscle cells in genital vasculature, promoting vasodilation and increased blood flow that supports arousal responses. The combination addresses sexual function at every level: desire (PT-141), bonding (Oxytocin), neurotransmitter support (NALT), hormonal optimization (Kisspeptin), and vascular function (VIP).
Protocol Notes: Take 1–2 hours before desired activity. Nausea is possible — take with light food if needed. Not for daily use.
Store at room temperature, away from light and moisture.
When sourcing PT-141 + Oxytocin + N-Acetyl L-Tyrosine + Kisspeptin + VIP (Capsule) for research purposes, the following quality benchmarks should be verified before use.
Store at room temperature, away from light and moisture.
The statements made within this website have not been evaluated by the US Food and Drug Administration. The products and information provided are not intended to diagnose, treat, cure, or prevent any disease. This website is intended for educational and research purposes only. Many peptides described on this site are not approved by the FDA for human therapeutic use and are classified as research chemicals. Nothing on this site constitutes medical advice.
Limited Evidence — Primarily animal studies with limited human data. Mechanism is plausible but clinical efficacy is unconfirmed.
Peptides commonly used alongside PT-141 + Oxytocin + N-Acetyl L-Tyrosine + Kisspeptin + VIP (Capsule) for synergistic effects.
Growth Hormone Releasing Hormone Analog
A short-acting GHRH analog that produces physiological GH pulses when combined with a GHRP like Ipamorelin.
Learn More: CJC-1295 No DACGonadotropin
A naturally occurring gonadotropin that stimulates testosterone production and maintains testicular function during TRT.
Learn More: HCG